What Elevated Liver Tests Mean for Life Insurance
When an Asian applicant's liver function tests—specifically alanine aminotransferase (ALT) or aspartate aminotransferase (AST)—are above normal ranges, underwriters flag potential liver disease. Elevated enzymes suggest inflammation or damage, which can increase the risk of serious health events that insurers deem high‑risk. The result is higher premiums, limited coverage, or outright denial.
More from this site
Keep reading the latest coverage
Why Asians May Show Higher Liver Enzymes
Several factors can contribute: genetic predisposition to conditions such as non‑alcoholic fatty liver disease, higher prevalence of hepatitis B, dietary habits rich in alcohol or processed foods, and obesity rates that are rising in East Asian communities. These physiological realities influence statistical risk models insurers use.
Underwriting Criteria and Typical Thresholds
Most life insurers set a threshold of 1.5–2.0 times the upper limit of normal (ULN) for ALT/AST before they consider a test abnormal. Below that, the impact is minimal; above it, underwriting committees may request additional evidence. Some companies also look at the AST/ALT ratio: a ratio above 1 can signal cirrhosis, prompting stricter scrutiny.
Steps to Improve Your Standing
1. Medical Evaluation: Get a comprehensive liver panel, including hepatitis B surface antigen and hepatitis C antibody tests. A clear negative result can mitigate concerns.
2. Lifestyle Modification: Weight loss, reduced alcohol intake, and a balanced diet lower enzyme levels. Document progress with repeat labs.
3. Medical Documentation: Provide a physician's note explaining any transient causes (e.g., recent medication use) and evidence of ongoing management.
4. Shop Around: Some insurers specialize in high‑risk applicants or offer "high‑risk" policies with higher premiums but guaranteed coverage.
Choosing the Right Insurer
Not all insurers weigh liver enzymes equally. Companies like AIA, Prudential, and Manulife have different risk appetite thresholds. Compare their underwriting guidelines and consider a broker who can navigate these nuances.
Case Study: A 38‑Year‑Old Asian Male with Elevated ALT
John, a 38‑year‑old Korean male, had an ALT of 75 U/L (ULN 35 U/L). After a 6‑month weight‑loss program and a repeat test showing 48 U/L, he applied to two insurers. Company A accepted him with a 15% premium increase; Company B required a medical exam and offered a policy at 25% higher rates. The difference illustrates how small lab improvements can affect cost.
Key Takeaways
Elevated liver enzymes raise life insurance risk for Asians, but they are not an insurmountable barrier. Understanding thresholds, addressing modifiable risk factors, and selecting insurers with favorable high‑risk policies can secure coverage at reasonable rates.